5 options
Hope or hype : the obsession with medical advances and the high cost of false promises / Richard A. Deyo, Donald L. Patrick.
- Format:
- Book
- Author/Creator:
- Deyo, Richard A.
- Language:
- English
- Subjects (All):
- Medical innovations--United States--Evaluation.
- Medical innovations.
- Medical technology--United States--Evaluation.
- Medical technology.
- Medical care--Technological innovations--United States--Evaluation.
- Medical care.
- Medical care--United States--Evaluation.
- Medical innovations--Economic aspects--United States.
- Medical technology--United States--Cost effectiveness.
- Medical care--Technological innovations--United States--Cost effectiveness.
- Medical care, Cost of--United States.
- Medical care, Cost of.
- Physical Description:
- 1 online resource (352 p.)
- Edition:
- 1st ed.
- Place of Publication:
- New York : AMACOM, American Management Association, c2005.
- Language Note:
- English
- Summary:
- Hope or Hype' looks at what drives the American obsession with medical "miracles," revealing the roles of: equipment manufacturers and pharmaceutical companies; doctors and hospitals too quick to order surgery or expensive medications; the politicians; the press; and our own "technoconsumption" mindset.
- Contents:
- Can there be too much of a good thing? the hazards of uncritically embracing medical advances
- What's the problem? don't we need lifesaving new treatments?
- Medical innovations and American culture: the call of the sirens
- Why more isn't always better: red herrings, side effects, and superbugs
- Why newer isn't always better: unpleasant surprises, recalls, and learning curves
- Social hazards: what we lose by uncritical use of new treatments
- How things really work: opinion makers and regulators of medical advances
- What will you swallow? how drug companies get you to buy more expensive drugs than you may need
- Making friends, playing monopoly, and dirty tricks: other industry strategies
- Stacking the deck? how to get the "right" answer in clinical research
- "Cancer cured
- film at 11:00": the media's role in disseminating medical advances
- Doctors and hospitals: fueling the drive for new and more
- Advocacy groups: Mother Teresa's waiting room
- Holes in the safety net: the FDA and the FTC
- Ineffective. inferior or needlessly costly new drugs
- Medical devices that disappoint
- Ineffective or needlessly extensive surgery
- Weight loss technology: shedding pounds from your waistline or your wallet?
- For doctors: evidence-based medicine
- For insurers and researchers: pay now or pay more later
- For all decision makers: getting value for money
- For government: regulatory approaches to improve the dissemination of medical innovations
- For consumers: shared decision making.
- Useless, harmful, or marginal: popular treatments that caused unnecessary disability, dollar costs, or death
- Ineffective or inferior new drugs
- Crossing the threshold: improving the transition from "experimental" to "standard care"
- Notes:
- Bibliographic Level Mode of Issuance: Monograph
- Includes bibliographical references (p. [291]-326) and index.
- ISBN:
- 1-281-12625-X
- 9786611126254
- 0-8144-2859-2
- OCLC:
- 614665643
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.